nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.231	0.419	CbGbCtD
Rocuronium—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.165	0.299	CbGbCtD
Rocuronium—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.156	0.282	CbGbCtD
Rocuronium—Vascular resistance systemic—Salbutamol—chronic obstructive pulmonary disease	0.0692	0.334	CcSEcCtD
Rocuronium—CHRND—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA3—chronic obstructive pulmonary disease	0.0139	0.0573	CbGpPWpGaD
Rocuronium—CHRNA1—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0118	0.0489	CbGpPWpGaD
Rocuronium—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0112	0.0465	CbGpPWpGaD
Rocuronium—CHRND—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.011	0.0457	CbGpPWpGaD
Rocuronium—CHRNA1—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0101	0.0417	CbGpPWpGaD
Rocuronium—CHRND—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.00976	0.0404	CbGpPWpGaD
Rocuronium—CHRNA1—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00964	0.0399	CbGpPWpGaD
Rocuronium—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00956	0.0396	CbGpPWpGaD
Rocuronium—CHRNA1—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00939	0.0389	CbGpPWpGaD
Rocuronium—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00915	0.0379	CbGpPWpGaD
Rocuronium—CHRND—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.009	0.0373	CbGpPWpGaD
Rocuronium—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00892	0.0369	CbGpPWpGaD
Rocuronium—CHRNA1—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.0083	0.0344	CbGpPWpGaD
Rocuronium—CHRNA1—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00821	0.034	CbGpPWpGaD
Rocuronium—CHRND—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.00796	0.0329	CbGpPWpGaD
Rocuronium—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.00789	0.0326	CbGpPWpGaD
Rocuronium—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0078	0.0323	CbGpPWpGaD
Rocuronium—CHRNA1—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00766	0.0317	CbGpPWpGaD
Rocuronium—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00727	0.0301	CbGpPWpGaD
Rocuronium—CHRNA1—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.00677	0.028	CbGpPWpGaD
Rocuronium—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.00643	0.0266	CbGpPWpGaD
Rocuronium—Electrocardiogram abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00506	0.0244	CcSEcCtD
Rocuronium—Paralysis—Arformoterol—chronic obstructive pulmonary disease	0.00505	0.0244	CcSEcCtD
Rocuronium—Paralysis—Formoterol—chronic obstructive pulmonary disease	0.00505	0.0244	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.00346	0.0167	CcSEcCtD
Rocuronium—Wheezing—Montelukast—chronic obstructive pulmonary disease	0.00334	0.0161	CcSEcCtD
Rocuronium—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.00322	0.0155	CcSEcCtD
Rocuronium—HTR3A—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00291	0.012	CbGpPWpGaD
Rocuronium—Myopathy—Prednisolone—chronic obstructive pulmonary disease	0.00271	0.0131	CcSEcCtD
Rocuronium—HTR3A—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00259	0.0107	CbGpPWpGaD
Rocuronium—Asthma—Formoterol—chronic obstructive pulmonary disease	0.0022	0.0106	CcSEcCtD
Rocuronium—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.0106	CcSEcCtD
Rocuronium—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00217	0.0104	CcSEcCtD
Rocuronium—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00217	0.0104	CcSEcCtD
Rocuronium—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00216	0.0104	CcSEcCtD
Rocuronium—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.01	CcSEcCtD
Rocuronium—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00207	0.00998	CcSEcCtD
Rocuronium—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00205	0.00986	CcSEcCtD
Rocuronium—Myopathy—Prednisone—chronic obstructive pulmonary disease	0.00197	0.0095	CcSEcCtD
Rocuronium—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00195	0.00941	CcSEcCtD
Rocuronium—Hiccups—Prednisolone—chronic obstructive pulmonary disease	0.0019	0.00917	CcSEcCtD
Rocuronium—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00182	0.00877	CcSEcCtD
Rocuronium—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00165	0.00793	CcSEcCtD
Rocuronium—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.00792	CcSEcCtD
Rocuronium—SLCO1A2—Transport of organic anions—ALB—chronic obstructive pulmonary disease	0.00163	0.00674	CbGpPWpGaD
Rocuronium—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00162	0.00781	CcSEcCtD
Rocuronium—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00161	0.00774	CcSEcCtD
Rocuronium—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00157	0.00759	CcSEcCtD
Rocuronium—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00157	0.00759	CcSEcCtD
Rocuronium—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00157	0.00756	CcSEcCtD
Rocuronium—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00156	0.0075	CcSEcCtD
Rocuronium—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00155	0.00749	CcSEcCtD
Rocuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00155	0.0064	CbGpPWpGaD
Rocuronium—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00154	0.00741	CcSEcCtD
Rocuronium—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00153	0.00736	CcSEcCtD
Rocuronium—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00151	0.0073	CcSEcCtD
Rocuronium—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00149	0.00717	CcSEcCtD
Rocuronium—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00147	0.00707	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00143	0.00687	CcSEcCtD
Rocuronium—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.00138	0.00666	CcSEcCtD
Rocuronium—CHRNA1—ErbB2/ErbB3 signaling events—ERBB3—chronic obstructive pulmonary disease	0.00136	0.00562	CbGpPWpGaD
Rocuronium—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00639	CcSEcCtD
Rocuronium—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00639	CcSEcCtD
Rocuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00132	0.00544	CbGpPWpGaD
Rocuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00126	0.00522	CbGpPWpGaD
Rocuronium—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00604	CcSEcCtD
Rocuronium—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00604	CcSEcCtD
Rocuronium—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00603	CcSEcCtD
Rocuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00125	0.00517	CbGpPWpGaD
Rocuronium—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00591	CcSEcCtD
Rocuronium—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00589	CcSEcCtD
Rocuronium—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00589	CcSEcCtD
Rocuronium—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00122	0.00587	CcSEcCtD
Rocuronium—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00585	CcSEcCtD
Rocuronium—SLCO1A2—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.00121	0.00499	CbGpPWpGaD
Rocuronium—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.0057	CcSEcCtD
Rocuronium—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00564	CcSEcCtD
Rocuronium—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00564	CcSEcCtD
Rocuronium—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00561	CcSEcCtD
Rocuronium—CHRND—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00116	0.00481	CbGpPWpGaD
Rocuronium—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00561	CcSEcCtD
Rocuronium—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00556	CcSEcCtD
Rocuronium—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00551	CcSEcCtD
Rocuronium—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00533	CcSEcCtD
Rocuronium—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00529	CcSEcCtD
Rocuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00107	0.00444	CbGpPWpGaD
Rocuronium—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00504	CcSEcCtD
Rocuronium—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.005	CcSEcCtD
Rocuronium—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.005	CcSEcCtD
Rocuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00102	0.00422	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00101	0.00419	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000989	0.00409	CbGpPWpGaD
Rocuronium—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000986	0.00476	CcSEcCtD
Rocuronium—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000978	0.00472	CcSEcCtD
Rocuronium—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000977	0.00471	CcSEcCtD
Rocuronium—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000977	0.00471	CcSEcCtD
Rocuronium—CHRND—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000948	0.00392	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00094	0.00389	CbGpPWpGaD
Rocuronium—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000922	0.00445	CcSEcCtD
Rocuronium—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000922	0.00445	CcSEcCtD
Rocuronium—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000922	0.00444	CcSEcCtD
Rocuronium—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000904	0.00436	CcSEcCtD
Rocuronium—HTR3A—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000903	0.00374	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000891	0.00369	CbGpPWpGaD
Rocuronium—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000886	0.00427	CcSEcCtD
Rocuronium—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000886	0.00427	CcSEcCtD
Rocuronium—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000884	0.00426	CcSEcCtD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000877	0.00363	CbGpPWpGaD
Rocuronium—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000871	0.0042	CcSEcCtD
Rocuronium—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000868	0.00418	CcSEcCtD
Rocuronium—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000853	0.00411	CcSEcCtD
Rocuronium—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000836	0.00403	CcSEcCtD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000806	0.00334	CbGpPWpGaD
Rocuronium—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000796	0.00384	CcSEcCtD
Rocuronium—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000796	0.00384	CcSEcCtD
Rocuronium—CHRM2—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000793	0.00328	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000791	0.00327	CbGpPWpGaD
Rocuronium—Rash—Formoterol—chronic obstructive pulmonary disease	0.000789	0.00381	CcSEcCtD
Rocuronium—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000789	0.00381	CcSEcCtD
Rocuronium—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000789	0.0038	CcSEcCtD
Rocuronium—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000789	0.0038	CcSEcCtD
Rocuronium—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00078	0.00376	CcSEcCtD
Rocuronium—Rash—Montelukast—chronic obstructive pulmonary disease	0.000773	0.00373	CcSEcCtD
Rocuronium—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000773	0.00373	CcSEcCtD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000766	0.00317	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000758	0.00314	CbGpPWpGaD
Rocuronium—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000752	0.00363	CcSEcCtD
Rocuronium—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.00359	CcSEcCtD
Rocuronium—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.00359	CcSEcCtD
Rocuronium—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000744	0.00359	CcSEcCtD
Rocuronium—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000744	0.00359	CcSEcCtD
Rocuronium—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000728	0.00351	CcSEcCtD
Rocuronium—CHRND—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000727	0.00301	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00072	0.00298	CbGpPWpGaD
Rocuronium—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000717	0.00346	CcSEcCtD
Rocuronium—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000702	0.00339	CcSEcCtD
Rocuronium—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000678	0.00327	CcSEcCtD
Rocuronium—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000667	0.00322	CcSEcCtD
Rocuronium—CHRM2—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000667	0.00276	CbGpPWpGaD
Rocuronium—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000662	0.00319	CcSEcCtD
Rocuronium—SLCO1A2—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.000631	0.00261	CbGpPWpGaD
Rocuronium—CHRM2—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.00062	0.00257	CbGpPWpGaD
Rocuronium—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00062	0.00299	CcSEcCtD
Rocuronium—CHRNA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000618	0.00256	CbGpPWpGaD
Rocuronium—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000604	0.0025	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000587	0.00243	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.000562	0.00233	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000559	0.00231	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000548	0.00227	CbGpPWpGaD
Rocuronium—CHRM2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000521	0.00216	CbGpPWpGaD
Rocuronium—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000521	0.00251	CcSEcCtD
Rocuronium—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.0005	0.00241	CcSEcCtD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000498	0.00206	CbGpPWpGaD
Rocuronium—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000493	0.00238	CcSEcCtD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000485	0.00201	CbGpPWpGaD
Rocuronium—Shock—Prednisone—chronic obstructive pulmonary disease	0.000485	0.00234	CcSEcCtD
Rocuronium—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000481	0.00232	CcSEcCtD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000432	0.00179	CbGpPWpGaD
Rocuronium—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000428	0.00206	CcSEcCtD
Rocuronium—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.00206	CcSEcCtD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000409	0.00169	CbGpPWpGaD
Rocuronium—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000403	0.00194	CcSEcCtD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000364	0.00151	CbGpPWpGaD
Rocuronium—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000363	0.00175	CcSEcCtD
Rocuronium—CHRM2—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.000352	0.00146	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000352	0.00146	CbGpPWpGaD
Rocuronium—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00168	CcSEcCtD
Rocuronium—SLC22A1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000331	0.00137	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000323	0.00134	CbGpPWpGaD
Rocuronium—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000313	0.00151	CcSEcCtD
Rocuronium—Rash—Prednisone—chronic obstructive pulmonary disease	0.000311	0.0015	CcSEcCtD
Rocuronium—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00031	0.0015	CcSEcCtD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000309	0.00128	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.0003	0.00124	CbGpPWpGaD
Rocuronium—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000293	0.00141	CcSEcCtD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000292	0.00121	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000288	0.00119	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.000276	0.00114	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00027	0.00112	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000263	0.00109	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000244	0.00101	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000244	0.00101	CbGpPWpGaD
Rocuronium—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000238	0.000983	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000214	0.000884	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000209	0.000865	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000209	0.000864	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000202	0.000837	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000199	0.000823	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000179	0.000741	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000168	0.000697	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000159	0.000659	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000156	0.000645	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000153	0.000634	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000152	0.00063	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000141	0.000585	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.000581	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GC—chronic obstructive pulmonary disease	0.000138	0.000569	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000131	0.000543	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00013	0.00054	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.00013	0.000537	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000128	0.000529	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00012	0.000495	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000119	0.000494	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000117	0.000485	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000112	0.000462	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000111	0.000458	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00011	0.000454	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000106	0.000439	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000103	0.000428	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000103	0.000424	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.000422	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000101	0.00042	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000101	0.000416	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	9.99e-05	0.000413	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	9.47e-05	0.000392	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.34e-05	0.000387	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	9e-05	0.000372	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	8.98e-05	0.000372	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.93e-05	0.000369	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	8.39e-05	0.000347	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.17e-05	0.000338	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.01e-05	0.000332	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	7.97e-05	0.00033	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.9e-05	0.000327	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.81e-05	0.000323	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.7e-05	0.000319	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.52e-05	0.000311	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.43e-05	0.000308	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.93e-05	0.000287	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.78e-05	0.000281	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.59e-05	0.000273	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.34e-05	0.000262	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.25e-05	0.000259	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.21e-05	0.000257	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.99e-05	0.000248	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.65e-05	0.000234	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.49e-05	0.000227	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.43e-05	0.000225	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.21e-05	0.000216	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.14e-05	0.000213	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.13e-05	0.000212	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.04e-05	0.000209	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.95e-05	0.000205	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.83e-05	0.0002	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.82e-05	0.0002	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.81e-05	0.000199	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.79e-05	0.000198	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.58e-05	0.00019	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.56e-05	0.000189	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.54e-05	0.000188	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.41e-05	0.000183	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.01e-05	0.000166	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.81e-05	0.000158	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.75e-05	0.000155	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.53e-05	0.000146	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.5e-05	0.000145	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.32e-05	0.000137	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.28e-05	0.000136	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.09e-05	0.000128	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.03e-05	0.000125	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.95e-05	0.000122	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.73e-05	0.000113	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.71e-05	0.000112	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.48e-05	0.000102	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.46e-05	0.000102	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.37e-05	9.8e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.25e-05	9.33e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.2e-05	9.11e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.16e-05	8.92e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.81e-05	7.49e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.73e-05	7.15e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.65e-05	6.82e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.46e-05	6.05e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.39e-05	5.76e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.32e-05	5.47e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.19e-05	4.92e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.09e-05	4.51e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.07e-05	4.42e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.98e-06	3.71e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.22e-06	3.4e-05	CbGpPWpGaD
